Hostname: page-component-5c6d5d7d68-pkt8n Total loading time: 0 Render date: 2024-08-22T14:43:30.407Z Has data issue: false hasContentIssue false

Control of Nosocomial Methicillin-Resistant Staphylococcus aureus Where Shall We Send Our Hospital Director Next Time?

Published online by Cambridge University Press:  02 January 2015

Stephan Harbarth
Affiliation:
Infection Control Program, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
Didier Pittet*
Affiliation:
Infection Control Program, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
*
Infection Control Program, Department of Internal Medicine, Hôpitaux Universitaires de Genève, 1211 Geneva 14, Switzerland
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2003

References

1.Camus, A. The Plague. New York: Vintage Books; 1972.Google Scholar
2.Barrett, FF, McGehee, RF, Finland, M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. N Engl J Med 1968;279:441448.CrossRefGoogle ScholarPubMed
3.Teare, EL, Barrett, SP. Is it time to stop searching for MRSA? Stop the ritual of tracing colonised people. BMJ 1997;314:665666.CrossRefGoogle ScholarPubMed
4.Farrington, M, Redpath, C, Trundle, C, Coomber, S, Brown, NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus infection at a teaching hospital. QJM 1998;91:539548.CrossRefGoogle ScholarPubMed
5.Harbarth, S, Pittet, D. MRSA: a European currency of infection control. QJM 1998;91:519521.CrossRefGoogle Scholar
6.Diekema, DJ, Pfaller, MA, Schmitz, FJ, et al.Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32(suppl 2):S114S132.CrossRefGoogle ScholarPubMed
7.Harbarth, S, Albrich, W, Goldmann, DAHuebner, J. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 2001;1:251261.CrossRefGoogle ScholarPubMed
8.Vriens, M, Blok, H, Fluit, A, Troelstra, A, Van Der Werken, C, Verhoef, J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002;21:782786.CrossRefGoogle Scholar
9.Kotilainen, P, Routamaa, M, Peltonen, R, et al.Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003;9:169175.CrossRefGoogle ScholarPubMed
10.Simor, AE, Ofner-Agostini, M, Bryce, E, et al.The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001;165:2126.Google ScholarPubMed
11.Afif, W, Huor, P, Brassard, P, Loo, VG. Compliance with methicillin-resistant Staphylococcus aureus precautions in a teaching hospital. Am J Infect Control 2002;30:430433.CrossRefGoogle ScholarPubMed
12.Gastmeier, P, Geffers, C, Sohr, D, Schwab, F, Behnke, M, Ruden, H. Surveillance of nosocomial infections in intensive care units: current data and interpretations. Wien Klin Wochenschr 2003;115:99103.CrossRefGoogle ScholarPubMed
13.National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002;30:458475.CrossRefGoogle Scholar
14.Tenover, FC, Biddle, JW, Lancaster, MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001;7:327332.CrossRefGoogle ScholarPubMed
15.Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. JAMA 2002;288:824825.Google Scholar
16.Garner, JS. Guideline for isolation precautions in hospitals: the Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:5380.CrossRefGoogle ScholarPubMed
17.Centers for Disease Control and Prevention. MRSA: Information for Health Care Personnel. Atlanta, GA Centers for Disease Control and Prevention. Available at www.cdc.gov/ncidod/hip/ARESIST/mrsahcw.htm. Accessed March 5,2003.Google Scholar
18.Jernigan, JATitus, MG, Gröschel, DHM, Getchell-White, SI, Farr, BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496504.CrossRefGoogle ScholarPubMed
19.Vriens, MR, Fluit, AC, Troelstra, A, Verhoef, J, Van Der Werken, C. Are MRSA more contagious than MSSA in a surgical intensive care unit? Infect Control Hosp Epidemiol 2002;23:491494.CrossRefGoogle Scholar
20.Rubinovitch, B, Pittet, D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 2001;47:918.CrossRefGoogle ScholarPubMed
21.Lucet, JC, Chevret, S, Durand-Zaleski, I, Chastang, C, Régnier, B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003;163:181188.CrossRefGoogle Scholar
22.Saiman, L, Cronquist, AWu, F, et al.An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24:317321.CrossRefGoogle Scholar
23.Marshall, C, Harrington, G, Wolfe, RFairley, CK, Wesselingh, S, Spelman, D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003;24:322326.CrossRefGoogle Scholar
24.Muto, CAJernigan, JAOstrowsky, BE, et al.Guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362386.CrossRefGoogle ScholarPubMed
25.Mulligan, ME, Murray-Leisure, KA, Ribner, BS, et al.Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313328.CrossRefGoogle ScholarPubMed
26.Mermel, LA, Farr, BM, Sherertz, RJ, et al.Guidelines for the management of intravascular catheter and device-related infections. Infect Control Hosp Epidemiol 2001;22:222242.CrossRefGoogle Scholar
27.Boyce, JM, Pittet, D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002;23(suppl):S340.CrossRefGoogle ScholarPubMed
28.Harbarth, S. Handwashing: the Semmelweis lesson misunderstood? Clin Infect Dis 2000;30:990991.CrossRefGoogle ScholarPubMed
29.Hartstein, AI, Le Monte, AM, Iwamoto, PK. DNA typing and control of methicillin-resistant Staphylococcus aureus at two affiliated hospitals. Infect Control Hosp Epidemiol 1997;18:4248.CrossRefGoogle ScholarPubMed
30.PHLS. The first year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April 2001-March 2002. CDR Wkly 2002;12:117.Google Scholar
31.Chaix, C, Durand-Zaleski, I, Alberti, C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:17451751.CrossRefGoogle Scholar
32.Papia, G, Louie, M, Tralla, AJohnson, C, Collins, V, Simor, AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473477.CrossRefGoogle Scholar